Aberrant Glycosylation in Cancer: From Immune Checkpoint Mechanisms to Glycan-Targeted Therapeutics. // Glycoscience & Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050608526000406?dgcid=rss_sd_all
Aberrant Glycosylation in Cancer: From Immune Checkpoint Mechanisms to Glycan-Targeted Therapeutics. Glycoscience & Therapy. https://www.sciencedirect.com/science/article/pii/S3050608526000406?dgcid=rss_sd_all
“Aberrant Glycosylation in Cancer: From Immune Checkpoint Mechanisms to Glycan-Targeted Therapeutics.” Glycoscience & Therapy.
@article{article47255,
title = {Aberrant Glycosylation in Cancer: From Immune Checkpoint Mechanisms to Glycan-Targeted Therapeutics},
journal = {Glycoscience \& Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050608526000406?dgcid=rss_sd_all}
}